Nexus Biologics develops advanced biological therapies and medical devices for wound care and tissue regeneration. Their products aim to accelerate healing, reduce complications, and improve patient outcomes in various surgical and clinical settings.
Funding
Funding not disclosed
Founders
Product
Problem
Current wound care and tissue regeneration treatments can be slow, have complications, and may not always lead to optimal patient outcomes, especially in surgical and clinical settings. There is a need for advanced biological therapies and medical devices to accelerate healing and improve overall results.
Solution
Nexus Biologics provides a portfolio of regenerative medicine products designed to enhance patient care and improve outcomes. They offer a range of orthobiologic and aesthetic medicine solutions, including Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), Platelet-Rich Fibrin Matrix (PRFM), exosomes, Bone Marrow Concentrate (BMC), Bone Marrow Aspirate Concentrate (BMAC), and adipose solutions. These products are sourced from trusted manufacturers and suppliers to ensure high quality and reliability. Nexus Biologics aims to connect healthcare providers with innovative products and resources to improve patient outcomes through regenerative medicine.
Target Audience
Nexus Biologics serves healthcare providers in orthopedics and aesthetics, connecting them with innovative regenerative medicine products.
Features
- Comprehensive portfolio of regenerative medicine products
- Platelet-Rich Plasma (PRP) solutions for tissue repair
- Platelet-Rich Fibrin (PRF) products for wound healing
- Platelet-Rich Fibrin Matrix (PRFM) technologies for advanced regeneration
- Exosome therapies for cell communication and regeneration
- Bone Marrow Concentrate (BMC) solutions for orthopedic applications
- Bone Marrow Aspirate Concentrate (BMAC) products for bone regeneration
- Adipose solutions for soft tissue repair and regeneration